Waters Corporation, with its robust position in the healthcare sector, offers a diverse range of analytical products tailored for various industries. Consistent with its history of growth, the Waters segment leads the charge in innovative chromatography and mass spectrometry solutions. These attributes make the stock a solid contender in its industry, albeit with certain risks tied to market demands and technological shifts.
The stock maintains a fairly strong fundamental rating with varied performance across different financial metrics.
Category | Score | Visual |
---|---|---|
Discounted Cash Flow | 4 | |
Return on Equity | 5 | |
Return on Assets | 5 | |
Debt to Equity | 1 | |
Price to Earnings | 1 | |
Price to Book | 1 |
Comparing historical scores offers insights into the financial trajectory of the company.
Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
---|---|---|---|---|---|---|---|
2025-09-19 | 3 | 4 | 5 | 5 | 1 | 1 | 1 |
Previous | 0 | 4 | 5 | 5 | 1 | 1 | 1 |
Analysts provide a range of price targets, reflecting diverse market perspectives.
High | Low | Median | Consensus |
---|---|---|---|
465 | 315 | 385 | 387.8 |
The sentiment among analysts is moderate with a predominant lean towards 'Hold'.
Recommendation | Count | Visual |
---|---|---|
Strong Buy | 0 | |
Buy | 9 | |
Hold | 20 | |
Sell | 3 | |
Strong Sell | 0 |
Waters Corporation demonstrates a strong foundation in analytical instruments, serving various sectors, including healthcare, with precision solutions. Its financial scores show potential, particularly in Return on Equity and Assets, yet underlying indebtedness remains a concern. Market analysts suggest cautious optimism, with target prices reflecting possible growth. However, the predominance of 'Hold' ratings signals mixed sentiment about near-term stock performance. Investors should weigh the potential rewards against the inherent market and sector risks.